According to Bafna Pharmaceuticals latest financial reports the cash on hand of BAFNAPH is $794.25K, an increase of 34242.78% to 2022. At the end of 2022 company had $2.31K cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $794.25K | 34242.78% |
2022 | $2.31K | -97.41% |
2021 | $89.12K | -90.87% |
2020 | $975.79K | 5767.60% |
2019 | $16.63K | - |